A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

Clinical trial NCT05601219 · TERMINATED

Trial details

NCT number: NCT05601219
Sponsor: Adanate, Inc
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2022-11-15
Primary completion: 2024-10-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.